Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.
Front Immunol
; 12: 641937, 2021.
Article
en En
| MEDLINE
| ID: mdl-33868274
ABSTRACT
Ovarian cancer (OC) is still the leading cause of death among all gynecological malignancies, despite the recent progress in cancer therapy. Immune escape and drug resistance, especially platinum-based chemotherapy, are significant factors causing disease progression, recurrence and poor prognosis in OC patients. MicroRNAs(miRNAs) are small noncoding RNAs, regulating gene expression at the transcriptional level. Accumulating evidence have indicated their crucial roles in platinum resistance. Importantly, they also act as mediators of tumor immune escape/evasion. In this review, we summarize the recent study of miRNAs involved in platinum resistance of OC and systematically analyses miRNAs involved in the regulation of OC immune escape. Further understanding of miRNAs roles and their possible mechanisms in platinum resistance and tumor escape may open new avenues for improving OC therapy.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Regulación Neoplásica de la Expresión Génica
/
Escape del Tumor
/
Resistencia a Antineoplásicos
/
Carcinoma Epitelial de Ovario
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Front Immunol
Año:
2021
Tipo del documento:
Article